Navigation Links
'Show me the money!' MDA greenlights grants
Date:7/13/2009

TUCSON, Ariz., July 13, 2009At a time when federal and private funds for biomedical research have become scarce, the Muscular Dystrophy Association reasserts its leadership in the fight against muscle diseases by announcing grants to innovative research projects throughout America and in Canada.

"Federal support for the type of work we do has just about dried up, especially in the current economic climate. Simply put, without the support of MDA, this line of investigation could not be pursued by our lab," said Eric Schon, researcher at Columbia University Medical Center in New York.

MDA has committed over $2 billion to fund medical and scientific research, as well as clinical and client services, in its 55-year history.

"These new research grants, just announced at the July MDA Board of Directors meeting, support research to be conducted from 2009 through 2011, totaling almost $5 million. MDA committed approximately $43million to new and ongoing research in 2008," said MDA Chairman of the Board R. Rodney Howell.

There are no cures yet for most muscle diseases, but the research MDA has funded has created the basis for progressive treatments of muscular dystrophy, amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, and spinal muscular atrophy. It also served as the basis for a lifesaving therapy developed by Genzyme for a metabolic muscle disease called Pompe disease.

At Columbia University, Schon has been awarded a three-year $400,000 grant to continue research into diseases of the mitochondria caused by genetic mutations. Mitochondria are the powerhouse of the cell and, when they fail, can cause muscle weakness and pain, diabetes, blindness and heart disease, along with other debilitating and/or fatal conditions. Schon's research may provide the key for treating many muscle diseases.

MDA has awarded a three-year, $900,000 award to Jerry Mendell at Nationwide Children's Hospital in Columbus, Ohio for a study to combat heart disease in muscular dystrophy.

While advances in treatment of the devastating Duchenne muscular dystrophy (DMD) have prolonged boys' lives, physicians are seeing more heart disease develop in young men living with the disease.

"The longer patients with DMD live, the greater the risk of cardiac complications. In this study, we hope to improve cardiac care by establishing the best medication regimen and to look at the best time to start treatment to protect the patient from heart failure," Mendell said.

He added, "It is clear that without the support of MDA this study and others like it could not be done. MDA is devoted to the treatment of Duchenne and the progress that has been made to this date is the result of the MDA commitment."

At the Ottawa Hospital Research Institute, in Ottawa, Ontario, Associate Scientific Director Rashmi Kothary will be able to continue his research seeking answers to the biological processes that cause SMA. MDA is awarding Kothary $300,000 for three years.

Kothary is also affiliated with the University of Ottawa and like so many researchers, he is aware of and affected by the cutback in research funding. "The financial commitment from MDA is critical for the continued research in this area within my laboratory. It will contribute to the training of highly qualified personnel and trainees who will be the future scientists to tackle neuromuscular disease questions."

In San Diego, Hristelina Ilieva of the Ludwig Institute for Cancer Research has been awarded $180,000 over three years to study how defects in the blood-brain barrier contribute to amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. Ilieva hopes to find a way to use genetic therapy to treat hereditary ALS.

"It will also enable my final phase postdoctoral training; thereby providing me what I hope is a major career development opportunity that will form the basis for my own independent career, a career in which I can use both my MD and Ph.D. training in further development of therapies for ALS."

All projects seeking MDA funding are reviewed by leading experts on the Association's Medical Advisory Committee or Scientific Advisory Committee before being presented to the Board for approval.

In all, 272 research applications were submitted to MDA for potential funding. Currently MDA supports 333 research teams around the globe.


'/>"/>

Contact: Lila Petersen
lpetersen@mdausa.org
Muscular Dystrophy Association
Source:Eurekalert

Related biology news :

1. Research shows that invisible hand guides evolution of cooperative turn-taking
2. Report shows the power of US cities to mitigate climate change and steps they need to take to adapt
3. Nitrogen research shows how some plants invade, take over others
4. Clinical trial shows quadriplegics can operate powered wheelchair with tongue drive system
5. Brain malformations significantly associated with preterm birth, Wake Forest research shows
6. New research shows dinosaurs may have been smaller than we thought
7. Environmental cues control reproductive timing and longevity, University of Minnesota study shows
8. Gene predicts how brain responds to fatigue, human study shows
9. Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
10. Study shows Chronix technology using serum DNA can identify early presence of disease
11. CU-Boulder study shows Maya intensively cultivated manioc 1,400 years ago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Minnesota (PRWEB) , ... January 19, 2017 , ... ... research organization with services spanning the full spectrum of drug and device development, ... research services to pharma/device companies and clinicians, today announced Verified Clinical Trials ...
(Date:1/19/2017)... , Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: ... personalized immune therapies for operable and inoperable solid tumor ... Chief Technical Officer of NW Bio, will present at ... 2017, at the Hyatt Regency Hotel in ... chair the session entitled "New Therapeutic Approaches – Expanding ...
(Date:1/19/2017)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ), ... a live webcast of its Annual Meeting of Shareholders on Tuesday, ... webcast can be accessed from the BD corporate website at ... 2017. ... BD BD is a global medical technology company that is ...
(Date:1/18/2017)... to a new market research report "In situ Hybridization Market by Technique (FISH, ... Laboratories, Academic and Research Institutions) - Global Forecast to 2021" published by MarketsandMarkets, ... 557.1 Million in 2016, growing at a CAGR of 5.8%. ... ... Logo ...
Breaking Biology Technology: